ArticleCancer cell2010
New views into the prostate cancer genome.
Article in Cancer cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.Oncotarget · 2018Article
- Structure and interactions of the CS domain of human H/ACA RNP assembly protein Shq1.Journal of molecular biology · 2015Article
- Prognostic prostate tissue biomarkers of potential clinical use.Virchows Archiv : an international journal of pathology · 2014Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
Genomic analysis of prostate cancer has not answered key clinical questions such as "Which tumors are likely to recur?" or "Which pathways should we target for treatment?" The study by Taylor et al., initiated by the late William Gerald, published in this issue of Cancer Cell is a game changer.
Identifiers
20609345What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.